Helicobacter pylori and extragastric diseases -- other helicobacters

Antonio Gasbarrini1, Emilia Carloni, Giovanni Gasbarrini

  • 1Istituti di Patologia Medica e Medicina Interna, Universita Cattolica, Rome 00168, Italy. angiologia@rm.unicatt.it

Helicobacter
|November 18, 2003
PubMed

Insights

Helicobacter pylori infection is increasingly linked to extragastric diseases, with potential roles in cardiovascular and hepatobiliary conditions. Further research and improved detection methods are crucial for understanding these complex associations.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Gastroenterology

Background:

  • Helicobacter pylori (H. pylori) infection is a known cause of gastritis and peptic ulcers.
  • Emerging evidence suggests H. pylori and other Helicobacter species may contribute to extragastric conditions.
  • The role of specific strains, like CagA-positive H. pylori, is under investigation for various diseases.

Purpose of the Study:

  • To review the expanding role of Helicobacter pylori and related species in extragastric diseases.
  • To highlight the potential involvement of these bacteria in cardiovascular and hepatobiliary conditions.
  • To discuss advancements in Helicobacter detection and the use of animal models.

Main Methods:

  • Literature review of studies investigating H. pylori and extragastric diseases.
  • Analysis of evidence linking H. pylori, particularly CagA-positive strains, to cardiovascular diseases like stroke.
  • Examination of research on enterohepatic helicobacters in hepatobiliary diseases.
  • Overview of newly identified Helicobacter species and molecular detection techniques.
  • Discussion of Helicobacter felis as a model organism.

Main Results:

  • While definitive proof is often lacking, H. pylori is implicated in several extragastric diseases, notably hematologic conditions.
  • CagA-positive H. pylori strains may play a role in cardiovascular diseases, including stroke.
  • Enterohepatic helicobacters, beyond H. pylori, are increasingly recognized for their involvement in hepatobiliary diseases.
  • New Helicobacter species are continually being discovered, necessitating improved diagnostic tools.

Conclusions:

  • The association between H. pylori infection and extragastric manifestations is a growing area of research.
  • Further investigation is required to establish causal links and understand the mechanisms involved.
  • Advancements in molecular methods are essential for accurate diagnosis and the study of diverse Helicobacter species.

Related Concept Videos

Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease I: Introduction01:25

Peptic Ulcer Disease I: Introduction

Peptic ulcer disease (PUD) involves breaks in the gastrointestinal tract's mucosal lining, primarily in the stomach and duodenum, with less frequent occurrences in the lower esophagus or near the pylorus.Ulcers can be acute or chronic. Acute ulcers are short-lived with minimal inflammation and heal quickly after the irritant is removed. Chronic ulcers persist, may recur, and often cause scarring due to ongoing tissue damage. Superficial erosions affect only the mucosal layer and are called...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.